《大行報告》匯豐研究下調中芯(00981.HK)目標價至25元 評級「持有」
匯豐研究發表報告,指中芯國際(00981.HK)今年第四季的收入指引為按季增加11%至13%,大幅高過同行指引的增長4%,相信與其訂單推遲到第四季進行、造成第三季低基數有關,以及產品組合改善。該行表示,由於中芯盈利波動,並繼續受限於美國出售禁令,將其目標價由31元下調至25元,維持「持有」評級。
匯豐研究將今年和明年中芯的每股盈利預測分別上調3%和17%,至0.19美元和0.15美元,以反映中芯第四季的高收入指引,以及毛利率因為28納米晶圓產品佔比增加而改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.